MoneyWorks4Me

Ind-Swift Laboratories informs about Outcome of Board Meeting

13 Aug 2014 Evaluate

Ind-Swift Laboratories has informed that the Board of Directors of the Company at its meeting held on August 12, 2014, Issue of shares as per SEBI (ICDR) Guidelines to Promoters Group on preferential basis against the promoters contribution infused by the promoters under the CDR package of the Company.

The above information is a part of company’s filings submitted to BSE

 

 

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..